AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 266: R592-R598, 1994;
0363-6119/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poulin, P.
Right arrow Articles by Pittman, Q. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulin, P.
Right arrow Articles by Pittman, Q. J.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 266, Issue 2 592-R598, Copyright © 1994 by American Physiological Society

ARTICLES

Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin

P. Poulin, A. Komulainen, Y. Takahashi and Q. J. Pittman
Neuroscience Research Group, University of Calgary, Alberta, Canada.

The role of oxytocin (OT) in the modulation of arginine vasopressin (AVP)-induced cardiovascular effects within the central nervous system was investigated in urethan-anesthetized rats. Intracerebroventricular injection of AVP (1-10 pmol) produced dose-dependent increases in mean arterial pressure (MAP) and heart rate (HR). These responses were enhanced in rats pretreated 24 h earlier with OT (10 pmol icv). The enhanced cardiovascular effects of AVP in OT-pretreated animals were dose dependent, blocked by the V1 antagonist d(CH2)5Tyr(Me)AVP, not evoked by OT alone, and occurred in the absence of changes in basal (nonstimulated) MAP and HR. In addition, central administration of AVP in OT-pretreated rats, but not in saline-pretreated controls, caused dose-dependent oscillations of the MAP and HR responses and, at higher doses, death of the animals. The enhanced cardiovascular actions of centrally injected AVP in OT-pretreated rats do not appear to be secondary to skeletal muscle contractions or the result of cerebral ischemia. Our data point to an interaction between the central oxytocinergic and vasopressinergic systems in cardiovascular control.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. T. Higa, E. Mori, F. F. Viana, M. Morris, and L. C. Michelini
Baroreflex control of heart rate by oxytocin in the solitary-vagal complex
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R537 - R545.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Gimpl and F. Fahrenholz
The Oxytocin Receptor System: Structure, Function, and Regulation
Physiol Rev, April 1, 2001; 81(2): 629 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. C. Braga, E. Mori, K. T. Higa, M. Morris, and L. C. Michelini
Central oxytocin modulates exercise-induced tachycardia
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1474 - R1482.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Dufloth, M. Morris, and L. C. Michelini
Modulation of exercise tachycardia by vasopressin in the nucleus tractus solitarii
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1271 - R1282.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online